Mayne Pharma Group Limited (MAYNF)
USD 3.06
(0.0%)
USD 3.06
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -15.3 Million | -43.12 Million | -16.61 Million | 47.25 Million | 99.77 Million | 106.6 Million |
| Net Income | -174.23 Million | -317.35 Million | -209.48 Million | -208.42 Million | -92.78 Million | -279.2 Million |
| Depreciation & Amortization | 71.62 Million | 65.44 Million | 55.18 Million | 68.18 Million | 84.56 Million | 94.49 Million |
| Deferred income taxes | -23.19 Million | 49.99 Million | 63.41 Million | -43.93 Million | -42.62 Million | -50.62 Million |
| Stock-based compensation | 4.09 Million | 6.77 Million | 4.57 Million | 7.74 Million | 6.98 Million | 9 Million |
| Change in working capital | 25.17 Million | 145.42 Million | -8.87 Million | -13.58 Million | 50.16 Million | -29.09 Million |
| Other non-cash items | 58.05 Million | -7.63 Million | 201.3 Million | 394.12 Million | 215.3 Million | 587.05 Million |
| Investing Cash Flow | 53.44 Million | 473.48 Million | -28.52 Million | -49.24 Million | -55.87 Million | -91.68 Million |
| Investments in PPE | -20.86 Million | -219.58 Million | -11.85 Million | -25.09 Million | -47.11 Million | -81.92 Million |
| Acquisitions | 6.85 Million | 842.21 Million | 5.16 Million | - | -8.75 Million | -9.76 Million |
| Investment purchases | - | -127.52 Million | - | - | - | -475 Thousand |
| Sales/Maturities of investments | 89.26 Million | - | - | - | - | 9.76 Million |
| Other Investing Activities | -34.72 Million | -21.62 Million | -21.84 Million | -24.15 Million | -8.75 Million | -9.29 Million |
| Financing Cash Flow | -19.85 Million | -431.47 Million | 27.6 Million | -40.44 Million | 4.52 Million | -15.55 Million |
| Debt repayment | -10.94 Million | -376.04 Million | -176.51 Million | -222.25 Million | -203.4 Million | -62.54 Million |
| Dividends payments | - | -45.29 Million | - | - | - | - |
| Common Stock Repurchased | -10.93 Million | -6.22 Million | - | - | - | - |
| Common Stock Issuance | - | 2.3 Million | - | - | 72 Thousand | 7.05 Million |
| Other Financing Activities | 2.03 Million | -6.22 Million | 204.11 Million | 181.81 Million | 207.85 Million | 39.94 Million |
| Accounts receivables | 5.91 Million | 118.7 Million | -66.12 Million | -3.2 Million | 67.51 Million | 9.43 Million |
| Accounts payables | -39.75 Million | 45.31 Million | 60.73 Million | 16.39 Million | -26.3 Million | -30.03 Million |
| Inventory | 25.59 Million | -12.12 Million | -2.41 Million | -25.92 Million | 13.07 Million | -6.43 Million |
| Other working capital | -6.33 Million | -6.47 Million | -1.06 Million | -856 Thousand | -4.12 Million | -2.06 Million |
| Cash at beginning of period | 92.61 Million | 97.08 Million | 97.98 Million | 137.78 Million | 89 Million | 87.31 Million |
| Cash at end of period | 110.06 Million | 101.71 Million | 96.67 Million | 97.98 Million | 137.78 Million | 89 Million |
| Capital Expenditure | -20.86 Million | -219.58 Million | -11.85 Million | -25.09 Million | -47.11 Million | -81.92 Million |
| Effect of forex changes on cash | -847 Thousand | -2.94 Million | 6.82 Million | -8.98 Million | 354 Thousand | 2.32 Million |
| Net cash flow / Change in cash | 17.45 Million | 4.63 Million | -1.3 Million | -39.8 Million | 48.78 Million | 1.69 Million |
| Free Cash Flow | -36.16 Million | -262.7 Million | -28.47 Million | 22.15 Million | 52.65 Million | 24.68 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -168.61 Million | -51.84 Million | -51.84 Million | -70.54 Million | -35.27 Million | -317.35 Million |
| Depreciation & Amortization | 68.45 Million | 17.1 Million | 17.1 Million | 35.87 Million | 17.6 Million | 65.44 Million |
| Deferred income taxes | -23.19 Million | -18.83 Million | - | -4.35 Million | - | 49.99 Million |
| Stock-based compensation | - | 788 Thousand | 788 Thousand | 1.25 Million | 1.25 Million | 6.77 Million |
| Change in working capital | -14.58 Million | 15.16 Million | 15.16 Million | -19.82 Million | -2.57 Million | 145.42 Million |
| Other non-cash items | 273.55 Million | 25.5 Million | 25.5 Million | 111.15 Million | 4.62 Million | -7.63 Million |
| Investing Cash Flow | 53.44 Million | -6.87 Million | -6.87 Million | 67.2 Million | 33.6 Million | 473.48 Million |
| Investments in PPE | -20.86 Million | -2.38 Million | -2.38 Million | -16.19 Million | -1.58 Million | -219.58 Million |
| Acquisitions | 6.85 Million | 6.85 Million | - | - | - | 842.21 Million |
| Investment purchases | - | - | - | - | - | -127.52 Million |
| Sales/Maturities of investments | 89.26 Million | -2.36 Million | - | 91.62 Million | - | - |
| Other Investing Activities | -21.81 Million | -4.49 Million | -4.49 Million | -8.22 Million | 35.19 Million | -21.62 Million |
| Financing Cash Flow | -25.59 Million | 175.5 Thousand | 175.5 Thousand | -23.72 Million | -10.1 Million | -431.47 Million |
| Debt repayment | -10.94 Million | -42 Thousand | - | -10.99 Million | - | -376.04 Million |
| Dividends payments | - | - | - | - | - | -45.29 Million |
| Common Stock Repurchased | -10.93 Million | - | - | -10.93 Million | -5.46 Million | -6.22 Million |
| Common Stock Issuance | - | - | - | - | - | 2.3 Million |
| Other Financing Activities | - | 175.5 Thousand | 175.5 Thousand | -4.63 Million | -4.63 Million | -6.22 Million |
| Accounts receivables | 5.91 Million | 80 Thousand | 80 Thousand | 5.75 Million | 2.87 Million | 118.7 Million |
| Accounts payables | -39.75 Million | -25.09 Million | - | -14.66 Million | - | 45.31 Million |
| Inventory | 25.59 Million | 11.21 Million | 11.21 Million | 3.16 Million | 1.58 Million | -12.12 Million |
| Other working capital | -6.33 Million | 3.86 Million | 3.86 Million | -14.07 Million | -7.03 Million | -6.47 Million |
| Cash at beginning of period | 101.71 Million | 109.22 Million | - | 101.71 Million | - | 97.08 Million |
| Cash at end of period | 112.38 Million | 112.38 Million | 420.5 Thousand | 109.22 Million | 8.3 Million | 101.71 Million |
| Capital Expenditure | -20.86 Million | -2.38 Million | -2.38 Million | -16.19 Million | -1.58 Million | -219.58 Million |
| Effect of forex changes on cash | - | 413.5 Thousand | 413.5 Thousand | -837 Thousand | -837 Thousand | -2.94 Million |
| Net cash flow / Change in cash | 10.67 Million | 3.16 Million | 420.5 Thousand | 7.51 Million | 8.3 Million | 4.63 Million |
| Free Cash Flow | -30.41 Million | 4.32 Million | 4.32 Million | -41.38 Million | -15.94 Million | -262.7 Million |
RIGG
UBAAF
GODAVARI
6939
PGD
BRBS